ClinicalTrials.gg
RecruitingNCT07685340Updated Jul 6, 2026

Dry Dynamic Cupping vs Instrument-Assisted Soft Tissue Mobilization for Chronic Myofascial Low Back Pain

An interventional study of Instrument Assisted Soft Tissue Mobilization (IASTM) and dry cupping in Chronic Myofascial Low Back Pain, sponsored by Ibadat International University, Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-06.

Sponsored by Ibadat International University, Islamabad · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Registered 5 months after the study started (first participant enrolled Jan 2026, registered Jun 2026).
  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
25 Years to 45 Years
Sex
All
01

Study summary

This study aims to compare the effects of Dry Dynamic Cupping and Instrument-Assisted Soft Tissue Mobilization (IASTM) in patients with chronic myofascial low back pain. The interventions will be evaluated for their effectiveness in reducing pain, improving functional disability, and enhancing quality of life. The findings may help identify a more effective treatment approach for managing chronic myofascial low back pain.

02

Conditions studied

  • Chronic Myofascial Low Back Pain

Keywords

  • chronic
  • myofascial
  • back pain
  • low back
  • low back pain
  • backache
03

In context

Bronchiolitis Obliterans Syndrome

714 studies on the registry are indexed under Bronchiolitis Obliterans Syndrome; 128 are open to participants now.

This study's planned enrollment of 48 is close to the median of 50 across 565 interventional studies indexed under Bronchiolitis Obliterans Syndrome.

Browse Bronchiolitis Obliterans Syndrome studies →

Lead sponsor

Ibadat International University, Islamabad is the lead sponsor of 59 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Chronic Myofascial Lower Back Pain > 3 months
  • Pain reproduced by palpation of Lumbar Para-Spinals, Quadratus Lumborum (QL) or Thoracolumbar Fascia.
  • Trigger Points will be diagnosed through Simons and Travell's Criteria
  • Age 25-45 years (young adults according to WHO classification)
  • Both genders

Exclusion criteria

Exclusion Criteria:

  • History of spinal surgery
  • Presence of inflammatory or neurological disorders
  • Facet joint dysfunction
  • Discogenic pain
  • Ligamentous pain
  • Pregnant females
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
48 participants (estimated)

Study arms

  • Active comparator
    Dry dynamic cupping group

    Participants in this group will receive Dry Dynamic Cupping therapy. The intervention will be administered for 2 weeks, with 3 treatment sessions per week, according to the standardized study protocol. The effects of the intervention will be evaluated on pain intensity, functional disability, and lumbar range of motion.

    Other: Instrument Assisted Soft Tissue Mobilization (IASTM) · Other: dry cupping

  • Placebo comparator
    IASTM Group

    Participants in this group will receive Instrument-Assisted Soft Tissue Mobilization (IASTM). The intervention will be administered for 2 weeks, with 3 treatment sessions per week, according to the standardized study protocol. The effects of the intervention will be evaluated on pain intensity, functional disability, and lumbar range of motion.

    Other: Instrument Assisted Soft Tissue Mobilization (IASTM) · Other: dry cupping

Interventions

  • OtherInstrument Assisted Soft Tissue Mobilization (IASTM)

    Participants in this group will receive Instrument-Assisted Soft Tissue Mobilization (IASTM). The intervention will be administered for 2 weeks, with 3 treatment sessions per week, according to the standardized study protocol. The effects of the intervention will be evaluated on pain intensity, functional disability, and lumbar range of motion.

  • Otherdry cupping

    Participants in this group will receive Dry Dynamic Cupping therapy. The intervention will be administered for 2 weeks, with 3 treatment sessions per week, according to the standardized study protocol. The effects of the intervention will be evaluated on pain intensity, functional disability, and lumbar range of motion.

06

What researchers measure

Primary outcomes

  1. NPRS

    Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). Changes in pain scores will be compared between the Dry Dynamic Cupping and IASTM groups.

    Time frame: Baseline and 2 Weeks Post-Intervention

Secondary outcomes

  1. ODI

    Functional disability related to low back pain will be assessed using the Oswestry Disability Index (ODI). Changes in disability scores will be compared between groups.

    Time frame: Baseline and 2 Weeks Post-Intervention

Other outcomes

  1. Inclinometer

    Lumbar range of motion (ROM) will be measured using an inclinometer. Flexion, extension, right and left side flexion, and right and left rotation will be assessed to evaluate changes in lumbar mobility following the intervention and compared between the Dry Dynamic Cupping and IASTM groups.

    Time frame: Baseline and 2 Weeks Post-Intervention

07

Study locations

1 of 1 sites recruiting
  • Mediplex Healthcare Center, Rawalpindi
    Rawalpindi, Punjab Province 46000, Pakistan
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Aug 2026, 7 months after the start.

Of 110 non-industry interventional studies with no phase under Bronchiolitis Obliterans Syndrome, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 50. This study's planned 7 months is below that.

Counting every sponsor, half of 122 studies reached it within 22 months; a quarter within 11 and three quarters within 54.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2026
First posted
Jul 6, 2026
StartActual
Jan 1, 2026
Primary completionEst.
Aug 15, 2026
CompletionEst.
Sep 1, 2026
Last update
Jul 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07685340
Lead sponsor
Ibadat International University, Islamabad
Responsible party
Sponsor
First posted
Jul 6, 2026
Start date
Jan 1, 2026
Primary completion
Aug 15, 2026 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Jul 6, 2026

Study contacts

MUHAMMAD ASHAR RAFI, DPT, MS-NMPT
Contact
ashar.rafi@uipt.iiui.edu.pk
0092-308-3407837
MUHAMMAD ARBAZ KHAN, DPT
Contact
arbazkhantastic3@gmail.com
0092-333-9001698
MUHAMMAD ASHAR RAFI, DPT, MS-NMPT
principal investigator · IBADAT INTERNATIONAL UNIVERSITY

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion